• +385 91 525-8267
  • info@onkolab.hr
logo
  • NASLOVNICA
  • O NAMA
  • CARIS LIFE SCIENCES
  • PROIZVODI
  • KAKO NARUČITI?
  • KONTAKT
  • NASLOVNICA
  • O NAMA
  • CARIS LIFE SCIENCES
  • PROIZVODI
  • KAKO NARUČITI?
  • KONTAKT

Novosti

  • Home
  •  
  • Novosti
    • 14 TRA. 17
    • 0

    Caris Life Sciences’ ADAPT Biotargeting System Identifies a Key Cell Surface Regulator of MYC as the Molecular Target of a Cytotoxic Aptamer

    Study Data Presented at AACR 2017 Annual Meeting Demonstrates the Ability of ADAPT Biotargeting System to Identify Molecular Targets for Anti-cancer Aptamers  IRVING, Texas, Apr. 3, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced results of a study that demonstrate the ability

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
    • 14 TRA. 17
    • 0

    Caris Life Sciences’ Results Demonstrate Ability of ADAPT Biotargeting System to Detect Breast Cancer Subtypes from Liquid Biopsy Samples

    Enriched Aptamer Libraries Identified 100% of Patients with ER+/PR+/HER2- Lobular Carcinoma Breast Cancer in Pilot Study Presented at AACR 2017 Annual Meeting IRVING, Texas, Apr. 3, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced results of a study that demonstrate the ability

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
    • 14 TRA. 17
    • 0

    New Data in Nature’s Scientific Reports Shows Caris Life Sciences’ ADAPT Platform Detects Breast Cancer in Women via Liquid Biopsy of Circulating Exosomes

    Results Demonstrate Potential of Unprecedented Technology Approach to Classify Women Regardless of Breast Density IRVING, Texas, Feb. 21, 2017 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the results of a study that demonstrates the ability of the company’s ADAPT Biotargeting System™ to

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
    • 14 TRA. 17
    • 0

    Caris Life Sciences and the Lustgarten Foundation Collaborate to Support Immunotherapy Clinical Trial for Pancreatic Cancer

    Leveraging Precision Medicine to Evaluate Immunotherapy Opportunities for the Most Lethal Form of Cancer IRVING, Texas, Jan. 18, 2017 – Caris Life Sciences, a leading innovator in molecular science, and the Lustgarten Foundation, the largest private funder of pancreatic cancer research, are collaborating to support a clinical trial evaluating the impact of immunotherapy in the treatment

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
    • 14 TRA. 17
    • 0

    Caris Life Sciences to Present at the 35th Annual J.P. Morgan Healthcare Conference

    IRVING, Texas, Jan. 5, 2017– Caris Life Sciences®, a leading innovator in molecular science, today announced that David D. Halbert, Chairman and Chief Executive Officer, will present at the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 at 10:30 a.m. PT in San Francisco, Calif.  Mr. Halbert will provide a corporate update

    Read more →
    • Posted in
    • Novosti
    • Posted by
    • Onkolab
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »
  • Caris Life Sciences®

    Saznaj Više

  • Molecular Intelligence®

    Saznaj Više

  • Novosti

    Saznaj Više

O Nama:

OnkoLab je mikro poduzeće osnovano 2015. godine kao rezultat entuzijazma stručnjaka u području molekularne biologije, a kao posljedica gubitka voljenih ljudi i nemogućnosti da im se pomogne u izboru najuspješnijeg liječenja.

Kako oboljeli u RH ne bi prolazili isto, na teritorij RH i okolne regije dovedena je vodeća kompanija u području molekularnog profiliranja.

Saznaj Više

Kako do Nas:

Za dodatne informacije molimo Vas da nas kontaktirate putem uputnika koji se nalazi na kontakt stranici.

  • Mobitel: +385 91 525-8267

  • E-mail: info@onkolab.hr

  • Ili ispunite upitnik na kontakt stranici

Brzi linkovi:

Saznajte više o molekularnom profiliranju tumora.

  • My Cancer

  • My Cancer genome

  • European Society For Medical Oncology

  • National Comprehensive Cancer Network

  • Cancer

  • Hrvatsko Onkološko Društvo

  • National Cancer Institute

2016 © Copyright - Onkolab.hr developed by Hr-Webdesign.com
Top